These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 24213852)

  • 21. TP53 family members and human cancers.
    Bénard J; Douc-Rasy S; Ahomadegbe JC
    Hum Mutat; 2003 Mar; 21(3):182-91. PubMed ID: 12619104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p73 Expression in human normal and tumor tissues: loss of p73alpha expression is associated with tumor progression in bladder cancer.
    Puig P; Capodieci P; Drobnjak M; Verbel D; Prives C; Cordon-Cardo C; Di Como CJ
    Clin Cancer Res; 2003 Nov; 9(15):5642-51. PubMed ID: 14654547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p73 and p63 sustain cellular growth by transcriptional activation of cell cycle progression genes.
    Lefkimmiatis K; Caratozzolo MF; Merlo P; D'Erchia AM; Navarro B; Levrero M; Sbisa' E; Tullo A
    Cancer Res; 2009 Nov; 69(22):8563-71. PubMed ID: 19861536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. One, two, three--p53, p63, p73 and chemosensitivity.
    Müller M; Schleithoff ES; Stremmel W; Melino G; Krammer PH; Schilling T
    Drug Resist Updat; 2006 Dec; 9(6):288-306. PubMed ID: 17287142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 Family isoforms.
    Bourdon JC
    Curr Pharm Biotechnol; 2007 Dec; 8(6):332-6. PubMed ID: 18289041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diverse p63 and p73 isoforms regulate Δ133p53 expression through modulation of the internal TP53 promoter activity.
    Marcel V; Petit I; Murray-Zmijewski F; Goullet de Rugy T; Fernandes K; Meuray V; Diot A; Lane DP; Aberdam D; Bourdon JC
    Cell Death Differ; 2012 May; 19(5):816-26. PubMed ID: 22075982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of p53 family members and CD44 in oral squamous cell carcinoma (OSCC) in relation to tumorigenesis.
    Bidaud P; Chasle J; Sichel F; Rousseau S; Petit P; Pottier D; Picquenot JM; Louis MY; Lechevrel M
    Histol Histopathol; 2010 Mar; 25(3):331-9. PubMed ID: 20054805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p63 and p73 in human cancer: defining the network.
    Deyoung MP; Ellisen LW
    Oncogene; 2007 Aug; 26(36):5169-83. PubMed ID: 17334395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family.
    Flores ER; Sengupta S; Miller JB; Newman JJ; Bronson R; Crowley D; Yang A; McKeon F; Jacks T
    Cancer Cell; 2005 Apr; 7(4):363-73. PubMed ID: 15837625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic expression of the p53 family members p63 and p73 in the mouse and human telencephalon during development and in adulthood.
    Hernández-Acosta NC; Cabrera-Socorro A; Morlans MP; Delgado FJ; Suárez-Solá ML; Sottocornola R; Lu X; González-Gómez M; Meyer G
    Brain Res; 2011 Feb; 1372():29-40. PubMed ID: 21114965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissue.
    Lo Iacono M; Monica V; Saviozzi S; Ceppi P; Bracco E; Papotti M; Scagliotti GV
    J Thorac Oncol; 2011 Mar; 6(3):473-81. PubMed ID: 21289519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A microRNA-dependent circuit controlling p63/p73 homeostasis: p53 family cross-talk meets therapeutic opportunity.
    Ory B; Ellisen LW
    Oncotarget; 2011 Mar; 2(3):259-64. PubMed ID: 21436470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53.
    Davison TS; Vagner C; Kaghad M; Ayed A; Caput D; Arrowsmith CH
    J Biol Chem; 1999 Jun; 274(26):18709-14. PubMed ID: 10373484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-specific p73 up-regulation mediates p63 dependence in squamous cell carcinoma.
    DeYoung MP; Johannessen CM; Leong CO; Faquin W; Rocco JW; Ellisen LW
    Cancer Res; 2006 Oct; 66(19):9362-8. PubMed ID: 17018588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p63 and p73 do not contribute to p53-mediated lymphoma suppressor activity in vivo.
    Perez-Losada J; Wu D; DelRosario R; Balmain A; Mao JH
    Oncogene; 2005 Aug; 24(35):5521-4. PubMed ID: 16007185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alteration of the MDM2-p73-P14ARF pathway related to tumour progression during urinary bladder carcinogenesis.
    Schlott T; Quentin T; Korabiowska M; Budd B; Kunze E
    Int J Mol Med; 2004 Nov; 14(5):825-36. PubMed ID: 15492852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Application of PLA Method for Detection of p53/p63/p73 Complexes in Situ in Tumour Cells and Tumour Tissue].
    Hrabal V; Nekulová M; Nenutil R; Holčaková J; Coates PJ; Vojtěšek B
    Klin Onkol; 2017; 30(Supplementum1):159-162. PubMed ID: 28471195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.
    Gaiddon C; Lokshin M; Ahn J; Zhang T; Prives C
    Mol Cell Biol; 2001 Mar; 21(5):1874-87. PubMed ID: 11238924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From p63 to p53 across p73.
    Strano S; Rossi M; Fontemaggi G; Munarriz E; Soddu S; Sacchi A; Blandino G
    FEBS Lett; 2001 Feb; 490(3):163-70. PubMed ID: 11223031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p73 and p63 regulate the expression of fibroblast growth factor receptor 3.
    Sayan AE; D'Angelo B; Sayan BS; Tucci P; Cimini A; Cerù MP; Knight RA; Melino G
    Biochem Biophys Res Commun; 2010 Apr; 394(3):824-8. PubMed ID: 20298673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.